J&J joins Bris­tol My­ers Squibb with $100M com­mit­ment to di­ver­si­ty ef­forts

A day af­ter the Bris­tol My­ers Squibb Foun­da­tion launched a $100 mil­lion pro­gram to di­ver­si­fy clin­i­cal tri­als, John­son & John­son says it’s al­so com­mit­ting $100 mil­lion to health eq­ui­ty ef­forts.

“There is an ur­gent need to take on the in­equities root­ed in sys­temic racism that threat­en health in com­mu­ni­ties of col­or across the Unit­ed States,” CEO Alex Gorsky said in a state­ment. “That’s why John­son & John­son is fo­cus­ing its ef­forts and com­mit­ting $100 mil­lion to ad­dress racial and so­cial in­jus­tice as the crit­i­cal pub­lic health is­sue that it is.”

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN